These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26196695)

  • 61. Treatment of methicillin-resistant Staphylococcus aureus ventilator-associated pneumonia with high-dose vancomycin or linezolid.
    Hamilton LA; Christopher Wood G; Magnotti LJ; Croce MA; Martin JB; Swanson JM; Boucher BA; Fabian TC
    J Trauma Acute Care Surg; 2012 Jun; 72(6):1478-83. PubMed ID: 22695410
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Clinical factors affecting the efficacy of vancomycin in methicillin-resistant Staphylococcus aureus pneumonia.
    Shimazaki N; Hayashi H; Umeda K; Aoyama T; Iida H; Matsumoto Y
    Int J Clin Pharmacol Ther; 2010 Aug; 48(8):534-41. PubMed ID: 20650045
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Efficacy of linezolid compared to vancomycin in an experimental model of pneumonia induced by methicillin-resistant Staphylococcus aureus in ventilated pigs.
    Martinez-Olondris P; Rigol M; Soy D; Guerrero L; Agusti C; Quera MA; Li Bassi G; Esperatti M; Luque N; Liapikou M; Filella X; Marco F; de la Bellacasa JP; Torres A
    Crit Care Med; 2012 Jan; 40(1):162-8. PubMed ID: 21926613
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
    Estes L; Orenstem R
    Clin Ther; 2007 Apr; 29(4):759-60; author reply 760-1. PubMed ID: 17617300
    [No Abstract]   [Full Text] [Related]  

  • 65. Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
    Estes L; Orenstein R
    Clin Ther; 2007 Feb; 29(2):381-3; author reply 383-4. PubMed ID: 17472831
    [No Abstract]   [Full Text] [Related]  

  • 66. Methicillin-resistant Staphylococcus aureus pneumonia after thoracic surgery: successful treatment with linezolid after failed vancomycin therapy.
    Salerno D; Vahid B; Marik PE
    Ann Thorac Surg; 2007 May; 83(5):1888-91. PubMed ID: 17462428
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Subtherapeutic linezolid concentrations in a patient with morbid obesity and methicillin-resistant Staphylococcus aureus pneumonia: case report and review of the literature.
    Muzevich KM; Lee KB
    Ann Pharmacother; 2013 Jun; 47(6):e25. PubMed ID: 23673532
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Outcomes Associated With De-escalating Therapy for Methicillin-Resistant Staphylococcus aureus in Culture-Negative Nosocomial Pneumonia.
    Cowley MC; Ritchie DJ; Hampton N; Kollef MH; Micek ST
    Chest; 2019 Jan; 155(1):53-59. PubMed ID: 30621854
    [TBL] [Abstract][Full Text] [Related]  

  • 69. What is the best therapeutic approach to methicillin-resistant Staphylococcus aureus pneumonia?
    Peyrani P; Ramirez J
    Curr Opin Infect Dis; 2015 Apr; 28(2):164-70. PubMed ID: 25692268
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Vancomycin dosing for methicillin-resistant staphylococcus aureus nosocomial pneumonia.
    Hall RG; Adams-Huet B
    Chest; 2007 Sep; 132(3):1100-1; author reply 1102-3. PubMed ID: 17873214
    [No Abstract]   [Full Text] [Related]  

  • 71. Vancomycin dosing for pneumonia in critically ill trauma patients.
    Patanwala AE; Norris CJ; Nix DE; Kopp BJ; Erstad BL
    J Trauma; 2009 Oct; 67(4):802-4. PubMed ID: 19820588
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Linezolid dampens neutrophil-mediated inflammation in methicillin-resistant Staphylococcus aureus-induced pneumonia and protects the lung of associated damages.
    Jacqueline C; Broquet A; Roquilly A; Davieau M; Caillon J; Altare F; Potel G; Asehnoune K
    J Infect Dis; 2014 Sep; 210(5):814-23. PubMed ID: 24620024
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Emergence of methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of late-onset nosocomial pneumonia in intensive care patients in the USA.
    Pasquale TR; Jabrocki B; Salstrom SJ; Wiemken TL; Peyrani P; Haque NZ; Scerpella EG; Ford KD; Zervos MJ; Ramirez JA; File TM;
    Int J Infect Dis; 2013 Jun; 17(6):e398-403. PubMed ID: 23375542
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Linezolid versus vancomycin in the treatment of pneumonia caused by Gram-positive cocci: meta-analysis of randomised controlled trials].
    Lin ZQ; Huang YL; Huang P; Chen Q
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Dec; 33(12):900-6. PubMed ID: 21211409
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Addition of rifampin to vancomycin for the treatment of pneumonias due to methicillin-resistant Staphylococcus aureus: caveat emptor.
    Ramsey KM; Mazer MA
    Crit Care Med; 2010 Jan; 38(1):326-7. PubMed ID: 20023486
    [No Abstract]   [Full Text] [Related]  

  • 76. PEGylated liposomal vancomycin: a glimmer of hope for improving treatment outcomes in MRSA pneumonia.
    Pumerantz AS
    Recent Pat Antiinfect Drug Discov; 2012 Dec; 7(3):205-12. PubMed ID: 22742394
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Methicillin-resistant Staphylococcus aureus nosocomial pneumonia: role of linezolid in the People's Republic of China.
    Lesher B; Gao X; Chen Y; Liu Z
    Clinicoecon Outcomes Res; 2016; 8():63-72. PubMed ID: 27069370
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Linezolid versus vancomycin cost in the treatment of staphylococcal pneumonia.
    Huon JF; Boutoille D; Caillon J; Orain J; Crochette N; Potel G; Abgueguen P; Moal F; Navas D
    Med Mal Infect; 2020 May; 50(3):252-256. PubMed ID: 31387813
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pharmacokinetic evaluation of linezolid administered intravenously in obese patients with pneumonia.
    Xie F; Mantzarlis K; Malliotakis P; Koulouras V; Degroote S; Koulenti D; Blot S; Boussery K; Van Bocxlaer J; Colin P;
    J Antimicrob Chemother; 2019 Mar; 74(3):667-674. PubMed ID: 30535122
    [TBL] [Abstract][Full Text] [Related]  

  • 80. An economic model to compare linezolid and vancomycin for the treatment of confirmed methicillin-resistant Staphylococcus aureus nosocomial pneumonia in Germany.
    Patel DA; Michel A; Stephens J; Weber B; Petrik C; Charbonneau C
    Infect Drug Resist; 2014; 7():273-80. PubMed ID: 25368526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.